Clinical trialNCT04057053CompletedEarly phase 1Interventional

Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty

SponsorMassachusetts Eye and Ear InfirmaryEnrollment10CataractFuchs' Endothelial Dystrophy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Primary aim of the study is to determine whether a rho kinase inhibitor, Netarsudil, can speed corneal clearance after DWEK. Secondary aim of the study is to investigate whether patient factors, such as baseline age, pachymetry, or endothelial cell count influence response to Netarsudil.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Emma E Davies
Massachusetts Eye and Ear Infirmary
Principal Investigator
clinicaltrials.gov ↗
Roberto Pineda
Massachusetts Eye and Ear Infirmary
Principal Investigator
clinicaltrials.gov ↗
Ula Jurkunas
Massachusetss Eye and Ear Infirmary
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Netarsudil 0.02% Ophthalmic Solution

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Oct 2018
Primary completion: 20 Dec 2020
Completion: 20 Dec 2020
Last update posted: 26 Jan 2021
Registered enrollment: 10
Registry id: NCT04057053

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.